| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 4 |
| Forrest at al. (procyclic) | no | yes: 4 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | yes | yes: 15 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 11 |
| NetGPI | no | yes: 0, no: 11 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005654 | nucleoplasm | 2 | 1 |
| GO:0005737 | cytoplasm | 2 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 1 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0006139 | nucleobase-containing compound metabolic process | 3 | 12 |
| GO:0006163 | purine nucleotide metabolic process | 5 | 12 |
| GO:0006164 | purine nucleotide biosynthetic process | 6 | 12 |
| GO:0006167 | AMP biosynthetic process | 8 | 11 |
| GO:0006188 | IMP biosynthetic process | 8 | 12 |
| GO:0006189 | 'de novo' IMP biosynthetic process | 9 | 11 |
| GO:0006725 | cellular aromatic compound metabolic process | 3 | 12 |
| GO:0006753 | nucleoside phosphate metabolic process | 4 | 12 |
| GO:0006793 | phosphorus metabolic process | 3 | 12 |
| GO:0006796 | phosphate-containing compound metabolic process | 4 | 12 |
| GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
| GO:0008152 | metabolic process | 1 | 12 |
| GO:0009058 | biosynthetic process | 2 | 12 |
| GO:0009117 | nucleotide metabolic process | 5 | 12 |
| GO:0009123 | nucleoside monophosphate metabolic process | 5 | 12 |
| GO:0009124 | nucleoside monophosphate biosynthetic process | 6 | 12 |
| GO:0009126 | purine nucleoside monophosphate metabolic process | 6 | 12 |
| GO:0009127 | purine nucleoside monophosphate biosynthetic process | 7 | 12 |
| GO:0009150 | purine ribonucleotide metabolic process | 6 | 12 |
| GO:0009152 | purine ribonucleotide biosynthetic process | 7 | 12 |
| GO:0009156 | ribonucleoside monophosphate biosynthetic process | 7 | 12 |
| GO:0009161 | ribonucleoside monophosphate metabolic process | 6 | 12 |
| GO:0009165 | nucleotide biosynthetic process | 6 | 12 |
| GO:0009167 | purine ribonucleoside monophosphate metabolic process | 7 | 12 |
| GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 8 | 12 |
| GO:0009259 | ribonucleotide metabolic process | 5 | 12 |
| GO:0009260 | ribonucleotide biosynthetic process | 6 | 12 |
| GO:0009987 | cellular process | 1 | 12 |
| GO:0018130 | heterocycle biosynthetic process | 4 | 12 |
| GO:0019438 | aromatic compound biosynthetic process | 4 | 12 |
| GO:0019637 | organophosphate metabolic process | 3 | 12 |
| GO:0019693 | ribose phosphate metabolic process | 4 | 12 |
| GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 |
| GO:0034654 | nucleobase-containing compound biosynthetic process | 4 | 12 |
| GO:0044208 | 'de novo' AMP biosynthetic process | 9 | 11 |
| GO:0044237 | cellular metabolic process | 2 | 12 |
| GO:0044238 | primary metabolic process | 2 | 12 |
| GO:0044249 | cellular biosynthetic process | 3 | 12 |
| GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 12 |
| GO:0044281 | small molecule metabolic process | 2 | 12 |
| GO:0046033 | AMP metabolic process | 7 | 11 |
| GO:0046040 | IMP metabolic process | 7 | 12 |
| GO:0046390 | ribose phosphate biosynthetic process | 5 | 12 |
| GO:0046483 | heterocycle metabolic process | 3 | 12 |
| GO:0055086 | nucleobase-containing small molecule metabolic process | 3 | 12 |
| GO:0071704 | organic substance metabolic process | 2 | 12 |
| GO:0072521 | purine-containing compound metabolic process | 4 | 12 |
| GO:0072522 | purine-containing compound biosynthetic process | 5 | 12 |
| GO:0090407 | organophosphate biosynthetic process | 4 | 12 |
| GO:1901135 | carbohydrate derivative metabolic process | 3 | 12 |
| GO:1901137 | carbohydrate derivative biosynthetic process | 4 | 12 |
| GO:1901293 | nucleoside phosphate biosynthetic process | 5 | 12 |
| GO:1901360 | organic cyclic compound metabolic process | 3 | 12 |
| GO:1901362 | organic cyclic compound biosynthetic process | 4 | 12 |
| GO:1901564 | organonitrogen compound metabolic process | 3 | 12 |
| GO:1901566 | organonitrogen compound biosynthetic process | 4 | 12 |
| GO:1901576 | organic substance biosynthetic process | 3 | 12 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003824 | catalytic activity | 1 | 12 |
| GO:0004018 | N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity | 5 | 12 |
| GO:0016829 | lyase activity | 2 | 12 |
| GO:0016840 | carbon-nitrogen lyase activity | 3 | 12 |
| GO:0016842 | amidine-lyase activity | 4 | 12 |
| GO:0070626 | (S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido) succinate lyase (fumarate-forming) activity | 5 | 11 |
| GO:0000166 | nucleotide binding | 3 | 1 |
| GO:0005488 | binding | 1 | 1 |
| GO:0036094 | small molecule binding | 2 | 1 |
| GO:0097159 | organic cyclic compound binding | 2 | 1 |
| GO:1901265 | nucleoside phosphate binding | 3 | 1 |
| GO:1901363 | heterocyclic compound binding | 2 | 1 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 363 | 367 | PF00656 | 0.355 |
| CLV_NRD_NRD_1 | 267 | 269 | PF00675 | 0.389 |
| CLV_NRD_NRD_1 | 421 | 423 | PF00675 | 0.355 |
| CLV_PCSK_KEX2_1 | 267 | 269 | PF00082 | 0.314 |
| CLV_PCSK_KEX2_1 | 421 | 423 | PF00082 | 0.355 |
| CLV_PCSK_SKI1_1 | 163 | 167 | PF00082 | 0.364 |
| CLV_PCSK_SKI1_1 | 221 | 225 | PF00082 | 0.358 |
| CLV_PCSK_SKI1_1 | 362 | 366 | PF00082 | 0.371 |
| CLV_PCSK_SKI1_1 | 433 | 437 | PF00082 | 0.355 |
| CLV_PCSK_SKI1_1 | 84 | 88 | PF00082 | 0.328 |
| CLV_PCSK_SKI1_1 | 95 | 99 | PF00082 | 0.328 |
| DEG_APCC_DBOX_1 | 220 | 228 | PF00400 | 0.528 |
| DEG_APCC_DBOX_1 | 461 | 469 | PF00400 | 0.355 |
| DOC_CYCLIN_yClb5_NLxxxL_5 | 371 | 377 | PF00134 | 0.476 |
| DOC_CYCLIN_yCln2_LP_2 | 373 | 379 | PF00134 | 0.355 |
| DOC_MAPK_gen_1 | 41 | 49 | PF00069 | 0.431 |
| DOC_MAPK_gen_1 | 60 | 67 | PF00069 | 0.514 |
| DOC_MAPK_MEF2A_6 | 60 | 67 | PF00069 | 0.514 |
| DOC_PP2B_LxvP_1 | 225 | 228 | PF13499 | 0.564 |
| DOC_PP2B_LxvP_1 | 373 | 376 | PF13499 | 0.355 |
| DOC_USP7_MATH_1 | 383 | 387 | PF00917 | 0.344 |
| DOC_USP7_UBL2_3 | 118 | 122 | PF12436 | 0.431 |
| DOC_WW_Pin1_4 | 199 | 204 | PF00397 | 0.503 |
| DOC_WW_Pin1_4 | 27 | 32 | PF00397 | 0.507 |
| DOC_WW_Pin1_4 | 33 | 38 | PF00397 | 0.470 |
| DOC_WW_Pin1_4 | 466 | 471 | PF00397 | 0.355 |
| LIG_14-3-3_CanoR_1 | 268 | 278 | PF00244 | 0.499 |
| LIG_14-3-3_CanoR_1 | 41 | 49 | PF00244 | 0.512 |
| LIG_14-3-3_CanoR_1 | 50 | 59 | PF00244 | 0.530 |
| LIG_14-3-3_CanoR_1 | 84 | 91 | PF00244 | 0.515 |
| LIG_14-3-3_CanoR_1 | 95 | 100 | PF00244 | 0.513 |
| LIG_Actin_WH2_2 | 374 | 391 | PF00022 | 0.459 |
| LIG_Actin_WH2_2 | 70 | 86 | PF00022 | 0.517 |
| LIG_AP2alpha_1 | 255 | 259 | PF02296 | 0.434 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.750 |
| LIG_BRCT_BRCA1_1 | 29 | 33 | PF00533 | 0.361 |
| LIG_deltaCOP1_diTrp_1 | 251 | 259 | PF00928 | 0.461 |
| LIG_FHA_1 | 10 | 16 | PF00498 | 0.615 |
| LIG_FHA_1 | 270 | 276 | PF00498 | 0.509 |
| LIG_FHA_1 | 44 | 50 | PF00498 | 0.511 |
| LIG_FHA_1 | 456 | 462 | PF00498 | 0.495 |
| LIG_FHA_2 | 101 | 107 | PF00498 | 0.565 |
| LIG_FHA_2 | 115 | 121 | PF00498 | 0.395 |
| LIG_FHA_2 | 137 | 143 | PF00498 | 0.528 |
| LIG_FHA_2 | 147 | 153 | PF00498 | 0.506 |
| LIG_FHA_2 | 271 | 277 | PF00498 | 0.503 |
| LIG_GBD_Chelix_1 | 412 | 420 | PF00786 | 0.355 |
| LIG_IRF3_LxIS_1 | 351 | 358 | PF10401 | 0.419 |
| LIG_LIR_Apic_2 | 187 | 191 | PF02991 | 0.516 |
| LIG_LIR_Apic_2 | 423 | 428 | PF02991 | 0.355 |
| LIG_LIR_Gen_1 | 140 | 148 | PF02991 | 0.517 |
| LIG_LIR_Gen_1 | 276 | 284 | PF02991 | 0.514 |
| LIG_LIR_Gen_1 | 301 | 311 | PF02991 | 0.503 |
| LIG_LIR_Gen_1 | 406 | 416 | PF02991 | 0.342 |
| LIG_LIR_Gen_1 | 469 | 476 | PF02991 | 0.360 |
| LIG_LIR_Gen_1 | 54 | 63 | PF02991 | 0.528 |
| LIG_LIR_Gen_1 | 98 | 107 | PF02991 | 0.588 |
| LIG_LIR_Nem_3 | 140 | 146 | PF02991 | 0.516 |
| LIG_LIR_Nem_3 | 251 | 255 | PF02991 | 0.512 |
| LIG_LIR_Nem_3 | 261 | 266 | PF02991 | 0.545 |
| LIG_LIR_Nem_3 | 276 | 281 | PF02991 | 0.388 |
| LIG_LIR_Nem_3 | 301 | 306 | PF02991 | 0.503 |
| LIG_LIR_Nem_3 | 406 | 412 | PF02991 | 0.342 |
| LIG_LIR_Nem_3 | 469 | 474 | PF02991 | 0.347 |
| LIG_LIR_Nem_3 | 54 | 59 | PF02991 | 0.514 |
| LIG_LIR_Nem_3 | 98 | 102 | PF02991 | 0.588 |
| LIG_LYPXL_yS_3 | 247 | 250 | PF13949 | 0.503 |
| LIG_NRBOX | 176 | 182 | PF00104 | 0.583 |
| LIG_Pex14_2 | 255 | 259 | PF04695 | 0.503 |
| LIG_SH2_CRK | 278 | 282 | PF00017 | 0.528 |
| LIG_SH2_GRB2like | 278 | 281 | PF00017 | 0.543 |
| LIG_SH2_GRB2like | 310 | 313 | PF00017 | 0.431 |
| LIG_SH2_PTP2 | 305 | 308 | PF00017 | 0.608 |
| LIG_SH2_SRC | 170 | 173 | PF00017 | 0.426 |
| LIG_SH2_STAP1 | 271 | 275 | PF00017 | 0.513 |
| LIG_SH2_STAP1 | 278 | 282 | PF00017 | 0.488 |
| LIG_SH2_STAP1 | 476 | 480 | PF00017 | 0.514 |
| LIG_SH2_STAT3 | 271 | 274 | PF00017 | 0.528 |
| LIG_SH2_STAT3 | 310 | 313 | PF00017 | 0.564 |
| LIG_SH2_STAT3 | 61 | 64 | PF00017 | 0.589 |
| LIG_SH2_STAT5 | 127 | 130 | PF00017 | 0.517 |
| LIG_SH2_STAT5 | 170 | 173 | PF00017 | 0.494 |
| LIG_SH2_STAT5 | 263 | 266 | PF00017 | 0.508 |
| LIG_SH2_STAT5 | 271 | 274 | PF00017 | 0.484 |
| LIG_SH2_STAT5 | 305 | 308 | PF00017 | 0.503 |
| LIG_SH2_STAT5 | 310 | 313 | PF00017 | 0.503 |
| LIG_SH2_STAT5 | 473 | 476 | PF00017 | 0.421 |
| LIG_SH2_STAT5 | 52 | 55 | PF00017 | 0.528 |
| LIG_SH2_STAT5 | 69 | 72 | PF00017 | 0.514 |
| LIG_SH3_3 | 197 | 203 | PF00018 | 0.503 |
| LIG_SH3_3 | 393 | 399 | PF00018 | 0.255 |
| LIG_SUMO_SIM_par_1 | 464 | 469 | PF11976 | 0.372 |
| LIG_TRAF2_1 | 5 | 8 | PF00917 | 0.759 |
| LIG_TRFH_1 | 33 | 37 | PF08558 | 0.490 |
| LIG_UBA3_1 | 177 | 184 | PF00899 | 0.528 |
| LIG_UBA3_1 | 223 | 232 | PF00899 | 0.565 |
| LIG_UBA3_1 | 294 | 300 | PF00899 | 0.565 |
| LIG_WRC_WIRS_1 | 447 | 452 | PF05994 | 0.390 |
| MOD_CK1_1 | 2 | 8 | PF00069 | 0.746 |
| MOD_CK1_1 | 27 | 33 | PF00069 | 0.589 |
| MOD_CK2_1 | 136 | 142 | PF00069 | 0.431 |
| MOD_CK2_1 | 2 | 8 | PF00069 | 0.762 |
| MOD_CK2_1 | 270 | 276 | PF00069 | 0.503 |
| MOD_GlcNHglycan | 132 | 135 | PF01048 | 0.408 |
| MOD_GlcNHglycan | 22 | 25 | PF01048 | 0.625 |
| MOD_GlcNHglycan | 322 | 325 | PF01048 | 0.314 |
| MOD_GlcNHglycan | 351 | 354 | PF01048 | 0.482 |
| MOD_GlcNHglycan | 4 | 7 | PF01048 | 0.739 |
| MOD_GSK3_1 | 20 | 27 | PF00069 | 0.508 |
| MOD_GSK3_1 | 223 | 230 | PF00069 | 0.604 |
| MOD_GSK3_1 | 9 | 16 | PF00069 | 0.604 |
| MOD_N-GLC_1 | 100 | 105 | PF02516 | 0.402 |
| MOD_N-GLC_1 | 153 | 158 | PF02516 | 0.307 |
| MOD_NEK2_1 | 1 | 6 | PF00069 | 0.501 |
| MOD_NEK2_1 | 146 | 151 | PF00069 | 0.514 |
| MOD_NEK2_1 | 180 | 185 | PF00069 | 0.547 |
| MOD_NEK2_1 | 193 | 198 | PF00069 | 0.488 |
| MOD_NEK2_1 | 223 | 228 | PF00069 | 0.608 |
| MOD_NEK2_1 | 258 | 263 | PF00069 | 0.552 |
| MOD_NEK2_1 | 341 | 346 | PF00069 | 0.440 |
| MOD_NEK2_1 | 364 | 369 | PF00069 | 0.378 |
| MOD_PIKK_1 | 147 | 153 | PF00454 | 0.514 |
| MOD_PIKK_1 | 270 | 276 | PF00454 | 0.503 |
| MOD_PIKK_1 | 78 | 84 | PF00454 | 0.608 |
| MOD_PKA_2 | 269 | 275 | PF00069 | 0.592 |
| MOD_PKB_1 | 268 | 276 | PF00069 | 0.608 |
| MOD_Plk_1 | 100 | 106 | PF00069 | 0.555 |
| MOD_Plk_1 | 153 | 159 | PF00069 | 0.502 |
| MOD_Plk_1 | 365 | 371 | PF00069 | 0.355 |
| MOD_Plk_2-3 | 100 | 106 | PF00069 | 0.577 |
| MOD_Plk_2-3 | 455 | 461 | PF00069 | 0.502 |
| MOD_Plk_4 | 290 | 296 | PF00069 | 0.608 |
| MOD_Plk_4 | 365 | 371 | PF00069 | 0.370 |
| MOD_Plk_4 | 383 | 389 | PF00069 | 0.298 |
| MOD_Plk_4 | 415 | 421 | PF00069 | 0.355 |
| MOD_ProDKin_1 | 199 | 205 | PF00069 | 0.503 |
| MOD_ProDKin_1 | 27 | 33 | PF00069 | 0.504 |
| MOD_ProDKin_1 | 466 | 472 | PF00069 | 0.355 |
| MOD_SUMO_rev_2 | 114 | 124 | PF00179 | 0.514 |
| TRG_DiLeu_BaEn_3 | 218 | 224 | PF01217 | 0.608 |
| TRG_ENDOCYTIC_2 | 247 | 250 | PF00928 | 0.503 |
| TRG_ENDOCYTIC_2 | 263 | 266 | PF00928 | 0.514 |
| TRG_ENDOCYTIC_2 | 278 | 281 | PF00928 | 0.424 |
| TRG_ENDOCYTIC_2 | 305 | 308 | PF00928 | 0.503 |
| TRG_ENDOCYTIC_2 | 429 | 432 | PF00928 | 0.355 |
| TRG_ENDOCYTIC_2 | 56 | 59 | PF00928 | 0.514 |
| TRG_ER_diArg_1 | 266 | 268 | PF00400 | 0.589 |
| TRG_ER_diArg_1 | 420 | 422 | PF00400 | 0.355 |
| TRG_Pf-PMV_PEXEL_1 | 362 | 366 | PF00026 | 0.355 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0H3AL67 | Vibrio cholerae serotype O1 (strain ATCC 39541 / Classical Ogawa 395 / O395) | 49% | 100% |
| A0A0N1I0W7 | Leptomonas seymouri | 83% | 100% |
| A0A0S4JC64 | Bodo saltans | 71% | 100% |
| A0A1X0NMR7 | Trypanosomatidae | 72% | 100% |
| A0A3R7N1M2 | Trypanosoma rangeli | 74% | 100% |
| A3KN12 | Bos taurus | 24% | 98% |
| A4HS40 | Leishmania infantum | 91% | 100% |
| A5IGB3 | Legionella pneumophila (strain Corby) | 48% | 100% |
| A7LBL3 | Leishmania donovani | 91% | 100% |
| C9ZY37 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 70% | 100% |
| E9AK27 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 99% |
| O27580 | Methanothermobacter thermautotrophicus (strain ATCC 29096 / DSM 1053 / JCM 10044 / NBRC 100330 / Delta H) | 29% | 100% |
| O28041 | Archaeoglobus fulgidus (strain ATCC 49558 / DSM 4304 / JCM 9628 / NBRC 100126 / VC-16) | 31% | 100% |
| O58582 | Pyrococcus horikoshii (strain ATCC 700860 / DSM 12428 / JCM 9974 / NBRC 100139 / OT-3) | 25% | 100% |
| O66856 | Aquifex aeolicus (strain VF5) | 27% | 100% |
| P0AB89 | Escherichia coli (strain K12) | 50% | 100% |
| P0AB90 | Escherichia coli O6:H1 (strain CFT073 / ATCC 700928 / UPEC) | 50% | 100% |
| P12047 | Bacillus subtilis (strain 168) | 25% | 100% |
| P30566 | Homo sapiens | 23% | 99% |
| P44797 | Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) | 49% | 100% |
| P54822 | Mus musculus | 23% | 99% |
| P57351 | Buchnera aphidicola subsp. Acyrthosiphon pisum (strain APS) | 43% | 100% |
| P72478 | Streptococcus mutans serotype c (strain ATCC 700610 / UA159) | 27% | 100% |
| Q05911 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 27% | 100% |
| Q2FFI7 | Staphylococcus aureus (strain USA300) | 24% | 100% |
| Q2G2S0 | Staphylococcus aureus (strain NCTC 8325 / PS 47) | 24% | 100% |
| Q2YU66 | Staphylococcus aureus (strain bovine RF122 / ET3-1) | 24% | 100% |
| Q49YV3 | Staphylococcus saprophyticus subsp. saprophyticus (strain ATCC 15305 / DSM 20229 / NCIMB 8711 / NCTC 7292 / S-41) | 24% | 100% |
| Q4L7M3 | Staphylococcus haemolyticus (strain JCSC1435) | 25% | 100% |
| Q54J34 | Dictyostelium discoideum | 56% | 100% |
| Q58339 | Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) | 27% | 100% |
| Q5HEL4 | Staphylococcus aureus (strain COL) | 24% | 100% |
| Q5HN26 | Staphylococcus epidermidis (strain ATCC 35984 / RP62A) | 24% | 100% |
| Q5ZXD1 | Legionella pneumophila subsp. pneumophila (strain Philadelphia 1 / ATCC 33152 / DSM 7513) | 48% | 100% |
| Q6G825 | Staphylococcus aureus (strain MSSA476) | 24% | 100% |
| Q6GFE9 | Staphylococcus aureus (strain MRSA252) | 24% | 100% |
| Q7A0G9 | Staphylococcus aureus (strain MW2) | 24% | 100% |
| Q7A4Q3 | Staphylococcus aureus (strain N315) | 24% | 100% |
| Q89AM3 | Buchnera aphidicola subsp. Baizongia pistaciae (strain Bp) | 42% | 100% |
| Q8CRT6 | Staphylococcus epidermidis (strain ATCC 12228 / FDA PCI 1200) | 24% | 100% |
| Q8HXY5 | Macaca fascicularis | 24% | 99% |
| Q8K9Q7 | Buchnera aphidicola subsp. Schizaphis graminum (strain Sg) | 42% | 100% |
| Q99SX9 | Staphylococcus aureus (strain Mu50 / ATCC 700699) | 24% | 100% |
| Q9I0K9 | Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) | 50% | 100% |
| Q9RSE6 | Deinococcus radiodurans (strain ATCC 13939 / DSM 20539 / JCM 16871 / LMG 4051 / NBRC 15346 / NCIMB 9279 / R1 / VKM B-1422) | 27% | 100% |
| Q9U0T7 | Leishmania major | 90% | 100% |
| Q9UZ99 | Pyrococcus abyssi (strain GE5 / Orsay) | 26% | 100% |
| Q9X0I0 | Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) | 27% | 100% |
| Q9ZKA2 | Helicobacter pylori (strain J99 / ATCC 700824) | 25% | 100% |
| V5BE01 | Trypanosoma cruzi | 72% | 100% |